Our functional study using knockdown and ectopic expression approaches has confirmed the oncogenic role of Nogo-B in vitro and in vivo, and that Nogo-B promotes cancer cell growth through dysregulated metabolic programming. The gene discussed is RTN4; the disease is cancer.